Kwabena Owusu-Kyei

Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial

David Ishola, Daniela Manno, Muhammed O. Afolabi et al. · The Lancet Infectious Diseases · 2021 · 95 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +13

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial

Muhammed O. Afolabi, David Ishola, Daniela Manno et al. · The Lancet Infectious Diseases · 2021 · 93 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Coverage of intermittent preventive treatment of malaria in infants after four years of implementation in Sierra Leone

Augustin E Fombah, Haily Chen, Kwabena Owusu-Kyei et al. · Malaria Journal · 2023 · 18 citations · Full text

Public Health, Child Health, Infectious Disease Control +17

Asymptomatic Malaria Infection and the Immune Response to the 2-Dose Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen in Adults and Children

David Ishola, Osman Bah, Foday Suma Bangalie et al. · Clinical Infectious Diseases · 2022 · 15 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Immunisation coverage and factors associated with incomplete immunisation in children under two during the COVID-19 pandemic in Sierra Leone

Myrte Wassenaar, Augustin E Fombah, Haily Chen et al. · BMC Public Health · 2024 · 14 citations · Full text

Medicine, Child Health, Infectious Diseases +17